-

Digital Marketing Competency Report Reveals 2022 Ranking of Biopharma Brands Based on Digital Patient Experiences

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its second annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital patient experiences. The novel study evaluates the brands across five categories and 60 unique metrics to understand each one’s digital marketing presence.

The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of spend, time in market, therapeutic areas and impact on individual channels to give organizations unrivaled insight into not only their own assessment, but also their competitors.

“The rapid evolution in omnichannel execution and patient centricity has led to a hyperfocus on how brands invest and measure digital marketing effectiveness,” said Jerry Luciano, VP of Omnichannel Marketing, at TGaS Advisors, a division of Trinity Life Sciences. “Now more than ever, it is critical for organizations to understand what they should be doing to optimize the digital patient experience. This ranking helps put in context where some of the world’s most important brands stand and provides insight into how some of the top brands are excelling.”

Brands that topped the 2022 Digital Marketing Competency Report’s list include:

Learn what sets some brands apart from others. To download the summary of the report with the ranking of all 160+ brands, please visit TrinityLifeSciences.com or click here. The full report, including in-depth channel analysis and trends is available to members of the TGaS Omnichannel Marketing network.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom